Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10016423 Solid forms of nilotinib hydrochloride

Patent 10016423 was granted and assigned to Apotex on July, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 21 Aug, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12064430 Kinase inhibitor salts and compositions thereof
0
"update inverses"
Golden AI profile picture
Golden AI
edited on 21 Aug, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12064428 Kinase inhibitor salts and compositions thereof
0
Edits on 8 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 8 Dec, 2023
Edits made to:
Article (+257 characters)
Article

Patent abstract

A solid form of Nilotinib hydrochloride, which exists as a co-crystal of nilotinib hydrochloride and levulinic acid having a molar ratio of nilotinib hydrochloride to levulinic acid of 1:2, and a process for the preparation of the co-crystal.

Edits on 29 Apr, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 29 Apr, 2023
Edits on 30 Mar, 2023
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 30 Mar, 2023
Infobox
Is a
Patent
Patent
0
Patent Applicant
Apotex
Apotex
0
Current Assignee
Apotex
Apotex
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100164230
Date of Patent
July 10, 2018
0
Patent Application Number
155188950
Date Filed
October 15, 2015
0
Patent Citations Received
‌
US Patent 10940149 Kinase inhibitor salts and compositions thereof
0
‌
US Patent 11007195 Kinase inhibitor salts, and compositions thereof
0
‌
US Patent 11052088 Kinase inhibitor salts, and compositions thereof
0
Patent Primary Examiner
‌
Alexander R Pagano
0
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 26 Mar, 2023
Edits on 21 Mar, 2023
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 21 Mar, 2023
Edits on 26 Sep, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 26 Sep, 2022
Infobox
Is a
Patent
Patent
0
Patent Applicant
Apotex
Apotex
0
Current Assignee
Apotex
Apotex
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
100164230
Date of Patent
July 10, 2018
0
Patent Application Number
155188950
Date Filed
October 15, 2015
0
Patent Citations Received
‌
US Patent 10940149 Kinase inhibitor salts and compositions thereof
0
‌
US Patent 11007195 Kinase inhibitor salts, and compositions thereof
0
‌
US Patent 11052088 Kinase inhibitor salts, and compositions thereof
0
Patent Primary Examiner
‌
Alexander R Pagano
0
Edits on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 23 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
"update citations for inverse infoboxes"
Golden AI profile picture
Golden AI
edited on 22 Sep, 2022
Edits on 12 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 12 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11052088 Kinase inhibitor salts, and compositions thereof
Edits on 11 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 11 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 11007195 Kinase inhibitor salts, and compositions thereof
Edits on 10 Feb, 2022
"update inverses"
Golden AI profile picture
Golden AI
edited on 10 Feb, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
‌
US Patent 10940149 Kinase inhibitor salts and compositions thereof
Edits on 21 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 21 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 10016423 Solid forms of nilotinib hydrochloride

Infobox
Is a
Patent
Patent
Patent applicant
Apotex
Apotex
Current assignee
Apotex
Apotex
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
10016423
Date of patent
July 10, 2018
Patent application number
15518895
Date Filed
October 15, 2015
Patent primary examiner
‌
Alexander R Pagano

Find more entities like US Patent 10016423 Solid forms of nilotinib hydrochloride

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo